definiens: has the meaning set out in Clause 8.2 ; has the meaning set out in Clause 2.1 ; means ( i ) those materials listed in Part B Schedule 3 ; and ( ii ) any materials Controlled by UCLB ( free from any restriction or encumbrance ) which are n ot Program Materials or the [ * * ] ( as such term is defined in the [ * * ] ) and which have been used by AN and/or the AN Laboratory in connection with any of the ( a ) Programs ( other than the Second Serotype Program ) prior to and/or as of the Effective Date ; and /or ( b ) the Second Serotype Program before, on or after the Effective Date ; and/or ( c ) the Additional Programs before and/or as of, the Amendment Date ; means the use by UCLB of best endeavours provided that the foregoing shall not oblige UCLB to pay monies or incur external costs or expenses, but shall require internal management effort and activity to be deployed by UCLB management and AN using UCLB ’s best efforts and where requested by Liverco, UCLB ’s management and/or AN shall travel a nd attend meetings to procure the objective, with any reasonable third party travel and subsistence costs being met by Liverco ; [ * * ] ; has the meaning set out in Clause 2.4.9 ; means the patent application to be filed b y UCLB claiming the inventions derived from the [ * * ] Program including any described in Part F of Schedule 2 under the title [ * * ] Program Know How and/or [ * * ] Materials, and all Patent Rights derived therefrom ; means any AAV -directed gene t herapy product that is not an Original Product and ( i ) [ * * ] that [ * * ] set out [ * * ], and/or ( ii ) which would infringe any of the [ * * ] but for the licence granted to Liverco hereunder ; means the program of research defined in Schedule 1 under the title [ * * ] Program as conducted prior to the Amendment Date ; means ( i ) the [ * * ] Patent Rights and ( ii ) excluding Manufacturing Know -How, all Know -How described in Part F of Schedule 2 under the title [ * * ] Program Know How ; and ( iii ) the materials listed in Part F of Schedule 2 under the title [ * * ] Materials ( together with all IP in the same ) ; has the meaning set out in Clause 14.1 ; 6 Certain confidential information contained in this document, marked by [ * * ], has been omitted because the information ( i ) is not material and ( ii ) would likely cause competitive harm to the Company if publicly disclosed